Metformin was mostly studied in context of reversing the effects of insulin resistance on the insulin signaling pathway (Wu et al., 2015; Zhou et al., 2016; Zabielski et al., 2017; Bradley et al., 2019). Here, INS is linked to Insulin resistance.